GaryScottMarshallMD

PubMed

• 3 citations
  A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB).
  Gary S Marshall, Victoria Abbing-Karahagopian, Helen S Marshall, Silvia Cenci, James H Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff, Woo-Yun Sohn> ;Expert Review of Vaccines. 2023 Jun 6
• 1 citations
  Physician preferences for attributes of pediatric combination vaccines in the United States.
  Salome Samant, Tanaz Petigara, Jyoti Aggarwal, Monica Mercer, Christopher B Nelson, Evangelos Zormpas, Avril Melissa Houston, Ana Pena-Molina, Gary S Marshall> ;Current Medical Research and Opinion. 2022 Nov 1
• Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States.
  Gary S Marshall, Tanaz Petigara, Zhiwen Liu, Lara Wolfson, David Johnson, Michelle G Goveia, Ya-Ting Chen> ;The Pediatric Infectious Disease Journal. 2022 Sep 1
• Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years ...
  Gary S Marshall, Stephen I Pelton, Corwin A Robertson, Philipp Oster> ;Human Vaccines & Immunotherapeutics. 2022 Nov 30
• 10 citations
  Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review.
  Gary S Marshall, Jaime Fergie, Jessica Presa, Paula Peyrani> ;Infectious Diseases and Therapy. 2022 Jun 1
• 5 citations
  Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US.
  Parinaz K Ghaswalla, Gary S Marshall, Lindsay G S Bengtson, Ami R Buikema, Tim Bancroft, Eleena Koep, Patricia Novy, Cosmina S Hogea> ;JAMA Network Open. 2022 Apr 1
• Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281].
  Parinaz K Ghaswalla, Lindsay G S Bengtson, Gary S Marshall, Ami R Buikema, Tim Bancroft, Krista M Schladweiler, Eleena Koep, Patricia Novy, Cosmina S Hogea> ;Vaccine. 2022 Feb 23
• 2 citations
  Prevention of measles, mumps and rubella: 40 years of global experience with M-M-R.
  Barbara J Kuter, Gary S Marshall, Jaime Fergie, Elvira Schmidt, Manjiri Pawaskar> ;Human Vaccines & Immunotherapeutics. 2021 Dec 2
• 2 citations
  Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
  Gary S. Marshall, Parinaz Ghaswalla, Lindsay G S Bengtson, Ami R Buikema, Tim Bancroft, Eleena Koep, Patricia Novy, Cosmina Hogea> ;Clinical Infectious Diseases. 2021 Oct 28
• 3 citations
  Standardized Vaccine-Hesitant Patients in the Assessment of the Effectiveness of Vaccine Communication Training.
  Shanna M. Barton, Aaron W. Calhoun, Carrie Bohnert, Sara Multerer, Victoria A. Statler, Kristina A. Bryant, Daniel M. Arnold, Heather M. Felton, Patricia M. Purcell, M...> ;The Journal of Pediatrics. 2021 Oct 23
• 1 citations
  Use of M-M-R II outside of the routinely recommended age range - a systematic literature review
  Manjiri Pawaskar, Elvira Schmidt, Gary S. Marshall, Jaime Fergie, Elizabeth Richardson, Louise Parks Saldutti, Se Li, Monika Neumann, Linnea Koller, Barbara J. Kuter> ;Human Vaccines & Immunotherapeutics. 2021 Jun 15
• 7 citations
  Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
  Parinaz Ghaswalla, Lindsay G S Bengtson, Gary S. Marshall, Ami R Buikema, Tim Bancroft, Krista M. Schladweiler, Eleena Koep, Patricia Novy, Cosmina Hogea> ;Vaccine. 2021 Jan 8
• 43 citations
  Common genetic susceptibility loci link PFAPA syndrome, Behçet’s disease, and recurrent aphthous stomatitis
  Kalpana Manthiram, Silvia Preite, Fatma Dedeoglu, Selcan Demir, Seza Ozen, Kathryn M. Edwards, Sivia K. Lapidus, Alexander E. Katz, Henry M. Feder, Maranda Lawton, Gre...> ;Proceedings of the National Academy of Sciences of the United States of America. 2020 Jun 23
• 20 citations
  US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.
  Gary S. Marshall, Amanda F. Dempsey, Amit Srivastava, Raul E Isturiz> ;Journal of the Pediatric Infectious Diseases Society. 2020 Apr 30
• 9 citations
  Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months : A Phase III, Randomized, Noninferiority, L...
  Nicola P. Klein, Remon Abu-Elyazeed, Michael Povey, Mercedes Macias Parra, Javier Díez-Domingo, Anitta Ahonen, Tiina Korhonen, Juan Carlos Tinoco, Leonard B. Weiner, G...> ;Journal of the Pediatric Infectious Diseases Society. 2020 Apr 30
• 23 citations
  Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the chil...
  Gil Amarilyo, Deborah Rothman, Kalpana Manthiram, Kathryn M. Edwards, Suzanne C. Li, Gary S. Marshall, Cagri Yildirim-Toruner, Kathleen A. Haines, Polly J. Ferguson, G...> ;Pediatric Rheumatology Online Journal. 2020 Apr 15
• 12 citations
  Experts' opinion for improving global adolescent vaccination rates: a call to action.
  Chiara Azzari, Javier Díez-Domingo, Evelyn Eisenstein, Saul N. Faust, Andreas Konstantopoulos, Gary S. Marshall, Fernanda Rodrigues, Tino F. Schwarz, Catherine Weil-Ol...> ;European Journal of Pediatrics. 2020 Feb 18
• 4 citations
  The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1)
  Erinn S. Kellner, Pamela A. Rathbun, Gary S. Marshall, Leandra K. Tolusso, Teresa A. Smolarek, Miao Sun, Sharat Chandra, Jack J. Bleesing, Rebecca A. Marsh> ;Journal of Clinical Immunology. 2019 Nov 1
• 1 citations
  Long-term Health Outcomes of Patients Evaluated for Unexplained Fever in a Pediatric Infectious Diseases Clinic.
  Kathryn E Weakley, Gary S. Marshall, Victoria A. Statler> ;Journal of the Pediatric Infectious Diseases Society. 2019 Oct 24
• 1 citations
  Mittens and Booties Syndrome: A Unique Manifestation of Human Parechovirus Infection in Infants.
  Elizabeth H Ristagno, Gary S. Marshall> ;The Pediatric Infectious Disease Journal. 2019 Sep 1
• 12 citations
  Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.
  Victoria A. Statler, Frank R. Albano, Jolanta Airey, Daphne C. Sawlwin, Alison L Jones, Vince Matassa, Esther Heijnen, Jonathan Edelman, Gary S. Marshall> ;Vaccine. 2019 Jan 7
• 13 citations
  Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Pre...
  Scott A. Halperin, Catherine Donovan, Gary S. Marshall, Vitali Pool, Michael D. Decker, David R. Johnson, David P. Greenberg, Tdap Booster Investigators> ;Journal of the Pediatric Infectious Diseases Society. 2019 May 11
• 12 citations
  Vaccine Hesitancy, History, and Human Nature: The 2018 Stanley A. Plotkin Lecture.
  Gary S. Marshall> ;Journal of the Pediatric Infectious Diseases Society. 2019 Mar 28
• 9 citations
  Dismissal Policies for Vaccine Refusal.
  Gary S. Marshall, Sean T. O’Leary> ;JAMA Pediatrics. 2018 Nov 1
• 7 citations
  Evaluation of Prolonged and Recurrent Unexplained Fevers.
  Victoria A. Statler, Gary S. Marshall> ;Pediatric Annals. 2018 Sep 13
• Join now to see all

Journal Articles

• Dismissal Policies for Vaccine Refusal  
  Gary Marshall, MD, JAMA
• Characteristics of patients referred to a pediatric infectious diseases clinic with unexplained fever  
  Statler VA, Marshall GS, J Pediatr Infect Dis Soc, 1/1/2015
• Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age  
  Marshall GS, Pool V, Greenberg DP, Johnson DR, Sheng X, Decker MD, Clin Vac Immunol, 1/1/2014
• Prolonged and recurrent fevers in children  
  Marshall GS, J Infect, 1/1/2014
• Hemophagocytic lymphohistiocytosis induced by monocytic ehrlichiosis  
  Statler VA, Marshall GS, J Pediatr, 1/1/2014
• Cerebellitis and acute obstructive hydrocephalus associated with Mycoplasma pneumoniae infection  
  Schmucker RD, Ehret A, Marshall GS, Pediatr Infect Dis J, 1/1/2014
• Steve Jobs wrestles with the electronic health record  
  Marshall GS, JAMA Pediatrics, 1/1/2013
• Factors associated with receipt of two doses of varicella vaccine among adolescents in the United States  
  Kawai K, O’Brien MA, Conway JH, Marshall GS, Kuter BJ, Pediatr Infect Dis J, 1/1/2013
• Antibodies persist for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccin...  
  Marshall GS, Blatter M, Aris E, Mesaros N, Miller JM, Pediatr Infect Dis J, 1/1/2013
• Roots of vaccine hesitancy  
  Marshall GS, South Dakota Med, 1/1/2013
• Immunogenicity and safety of measles–mumps–rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis...  
  Bryant KA, McVernon J, Marchant CD, Nolan T, Marshall GS, Richmond P, Marshall H, Nissen M, Lambert SB, Aris E, Mesaros N, Miller JM, Hum Vacc Immunother, 1/1/2012
• The burden of infant meningococcal disease in the United States  
  Judelsohn R, Marshall GS, J Pediatr Infect Dis Soc, 1/1/2012
• Common variable immunodeficiency presenting with persistent parvovirus B19 infection  
  Adams STM, Schmidt KM, Cost KM, Marshall GS, Pediatrics, 1/1/2012
• A novel combined H influenzae type b–N meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers  
  Bryant KA, Marshall GS, Expert Rev Vaccines, 1/1/2011
• Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the i...  
  Marshall GS, Marchant CD, Blatter M, Friedland LR, Aris E, Miller JM, Human Vaccines, 1/1/2011
• Pimping Protection for the 21st Century  
  Marshall GS, Louisville Medicine, 1/1/2011
• A statement regarding personal belief exemption from immunization mandates  
  Vaccine Advocacy Committee of the Pediatric Infectious Diseases Society (Marshall GS), Pediatr Infect Dis J, 1/1/2011
• Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis ...  
  Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A, Pediatr Infect Dis J, 1/1/2011
• Immunogenicity and safety of H influenza type b-N meningitidis C/Y conjugate vaccine in infants  
  Bryant KA, Marshall GS, Marchant CD, Pavia-Ruz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Lestrate P, Boutriau D, Friedland LR, Miller JM, Pediatrics, 1/1/2011
• Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children  
  Leonardi M, Bromberg K, Baxter R, Gardner JL, Klopfer S, Nicholson O, Brockley M, Trammel J, Leamy V, Williams W, Kuter B, Schodel F (ProQuad Protocol 019 Study Team), Pediatrics, 1/1/2011
• Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when admi...  
  Bernstein HH, Noriega F, M5A07 Pentacel Study Group, Vaccine, 1/1/2011
• Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus to...  
  Marshall GS, Marchant CD, Blatter M, Aris E, Boutriau D, Poolman JT, Friedland LR, Miller JM, Pediatr Infect Dis J, 1/1/2010
• Parental vaccine concerns in Kentucky  
  Smith MJ, Woods CR, Marshall GS+, J Kentucky Med Assoc, 1/1/2009
• Use of standardized patients to examine physicians' communication strategies when addressing vaccine refusal: a pilot study  
  Bryant KA, Wesley GC, Wood JA, Hines C, Marshall GS+, Vaccine, 1/1/2009
• Combination vaccine use and vaccination quality in a managed care population  
  Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S, Amer J Manag Care, 1/1/2007
• Join now to see all

Books/Book Chapters

• The Vaccine Handbook: A Practical Guide for Clinicians 
  Marshall GSProfessional Communications, Inc., West Islip, NYEdition 5th,2015
• Principles and Practice of Pediatric Infectious Diseases 
  Chapter: Chronic Fatigue Syndrome 
  Page 1007 - 1015Marshall GS, Carter BDEditors: Long SS, Pickering LK, Prober CG.Churchill Livingstone, New York, NYEdition 4th,2012
• The Vaccine Handbook: A Practical Guide for Clinicians 
  Marshall GSProfessional Communications, Inc., West Islip, NYEdition 4th,2012
• The Vaccine Handbook: A Practical Guide for Clinicians 
  Marshall GSProfessional Communications, Inc., West Islip, NYEdition 3rd,2010
• The Vaccine Handbook: A Practical Guide for Clinicians 
  Marshall GSProfessional Communications, Inc., West Islip, NYEdition 2nd,2008
• The Vaccine Handbook: A Practical Guide for Clinicians. 
  Marshall GS (contributing authors: Penelope H. Dennehy, David P. Greenberg, Paul A. Offit, Tina Q. Tan)Lippincott Williams & Wilkins, Philadelphia, PA2003
• Current Problems in Pediatrics 
  Chapter: New Developments: Diagnosis and Management of Chronic Fatigue in Children and Adolescents 
  Page 281 - 293Carter BD, Marshall GSEditors: Winter RJ.Mosby-Year Book, St. Louis, MO1995
• Molecular Aspects of Human Cytomegalovirus Diseases 
  Chapter: Vaccine Strategies for the Prevention of Cytomegalovirus Disease 
  Page 283 - 300Marshall GS, Plotkin SAEditors: Huang E-S, Becker Y.Springer-Verlag, Berlin, Germany1993
• Current Therapy in Pediatric Infectious Disease 
  Chapter: Chronic Fatigue Syndrome 
  Page 302 - 306Marshall GSEditors: Kaplan S.Mosby-Year Book, St. Louis, MO1993
• The Human Herpesviruses 
  Chapter: Cytomegalovirus Vaccines 
  Page 381 - 395Marshall GS, Plotkin SAEditors: Lopez C, Whitley R, Roizman B.Raven Press, New York, NY1993
• Pediatric Primary Care: A Problem-Oriented Approach 
  Chapter: Acquired Immune Deficiency Syndrome 
  Page 541 - 554Marshall GSEditors: Schwartz MW.Year Book Medical Publishers, Chicago, IL1990
• Join now to see all

Abstracts/Posters

• Immunogenicity and safety of an investigational hexavalent vaccine against diphtheria, tetanus, pertussis (DTaP5), polio (IPV), Haemophilus influenzae type b (Hib; PRP...
  Block SL, Marshall GS+, Petrecz M, Flores S, Ngai A, Xu J, Foglia G, Lee AW, Protocol 005 and Protocol 006 Study Teams, American Academy of Pediatrics National Conference & Exhibition, Washington, DC, 1/1/2015
• Management of complicated para-pneumonic effusion and empyema with initial parenteral antibiotics and early switch to oral equivalent.
  Espinosa CM, Woods C, Marshall GS, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
• Vaccine coverage at milestone ages among infants in the United States, 2009-2012.
  Gebremeskel B, Zhang D, Goveia MG, Marshall GS, O’Brien MA, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
• A phase III study of the safety, tolerability and immunogenicity of an investigational combination vaccine against diphtheria, tetanus, pertussis (DTaP5), polio (IPV),...
  Marshall GS, Adams GL, Leonardi M, Petrecz M, Flores SA, Ngai AL, Xu J, Foglia G, Lee AW, Protocol 005 Study Team, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
• Characteristics of patients referred to a pediatric infectious diseases clinic with unexplained fever.
  Statler VA, Marshall GS, 52nd Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2014
• Factors associated with receipt of 2 doses of varicella vaccine among adolescents in the United States.
  Kawai K, O'Brien MA, Conway JH, Marshall GS, Kuter BJ, 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 1/1/2012
• Antibody persistence 5 years after the fourth dose of an investigational Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y tetanus toxoid (Hi...
  Marshall GS, Mesaros N, Aris E, Miller JM, 50th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 1/1/2012
• Persistence of immunity three years after receipt of an investigational Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y conjugate vaccine (...
  Marshall GS, Mesaros N, Aris E, Marchant CD, Blatter M, Miller JM, 45th Annual National Immunization Conference, Washington, DC, 1/1/2011
• Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY) was immunogenic and safe in 6414 infants.
  Bryant KA, Marshall GS, Marchant CD, Pavia-Ruz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Boutriau D, Mesaros N, Friedland LR, Miller JM, 44th Annual National Immunization Conference, Atlanta, GA, 1/1/2010
• Immune response to measles, mumps, rubella (MMR) and varicella (V) vaccine coadministered with a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis se...
  Bryant KA, McVernon J, Marchant CD, Nolan T, Marshall GS, Richmond P, Marshall H, Alexander K, Aris E, Mesaros N, Miller JM, Pediatric Academic Societies Meeting, Vancouver, British Columbia, Canada, 1/1/2010
• Parental vaccine concerns in Kentucky.
  Smith MJ, Woods CR, Marshall GS, 43rd National Immunization Conference, Dallas, TX, 1/1/2009
• An investigational H. influenzae type b–N. meningitides serogroups C & Y tetanus toxoid conjugate vaccine (HibMenCY) is highly immunogenic and well tolerated in infants.
  Bryant K, Marshall G, Marchant C, Ruiz P, Nolan T, Blatter M, Rinderknecht S, Boutriau D, Mesaros N, Friedland L, Miller J, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
• Persistence of immunity 1 year after 4 doses of an investigational H. influenzae type b (Hib) and N. meningitides serogroups C and Y conjugate vaccine.
  Marshall G, Marchant C, Blatter M, Aris E, Friedland L, Miller J, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
• Human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine co-administered with other vaccines in female adolescents.
  Wheeler CM, HPV-018 Study Group, 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 1/1/2009
• Immunogenicity of a 7-valent pneumococcal conjugate vaccine co-administered with an investigational H. influenzae type b-N. meningitidis serogroups C & Y conjugate vac...
  Miller J, Marshall G, Blatter M, Marchant C, Boutriau D, Friedland L, 46th Annual Meeting of the Infectious Diseases Society of America, Washington, DC, 1/1/2008
• Immunity to an investigational H. influenzae type b-N. meningitidis serogroups C & Y conjugate vaccine measured in a serum bactericidal activity assay using human comp...
  Miller J, Marshall G, Marchant C, Blatter M, Boutriau D, Friedland L, 46th Annual Meeting of the Infectious Diseases Society of America, Washington, DC, 1/1/2008
• Coverage rates among children receiving combination versus component vaccines in a state Medicaid program.
  Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
• Impact of first-year DTaP doses on the timeliness of the fourth dose of DTaP among children in a state Medicaid population.
  Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
• Timeliness of childhood immunizations in a state Medicaid population.
  Marshall GS, Happe LE, Russell A, 40th National Immunization Conference, Atlanta, GA, 1/1/2006
• Use of standardized patients to examine private practice physicians' communication strategies when addressing vaccine refusal: Advantages and barriers to the research ...
  Wesley GC, Bryant KA, Wood JA, Marshall GS, 12th International Ottawa Conference on Clinical Competence, New York, NY, 1/1/2006
• Use of standardized mothers to study physician responses to vaccine refusal.
  Bryant KA, Wesley GC, Wood JA, Hines CL, Marshall GS, Pediatric Academic Societies Meeting, San Francisco, CA, 1/1/2006
• Incidence of intussusception with the pentavalent (human-bovine) reassortant rotavirus vaccine (PRV) is similar to placebo.
  Vesikari T, Matson D, van Damme P, Heyse J, Dallas M, Goveia M, Black S, Shinefield H, Christie C, Rodriguez Z, Boslego J, Dennehy P, Marshall G, Gothefors L, Miller J..., 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Valencia, Spain, 1/1/2005
• Clinical and laboratory features of Rocky Mountain spotted fever (RMSF) and human monocytic ehrlichiosis (HME) in children.
  Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, Jacobs RF, Pediatric Academic Societies Meeting, Washington, DC, 1/1/2005
• Safety, tolerability, and immunogenicity of M-M-R™II with recombinant human albumin (rHA) evaluated in children 12 to 18 months of age.
  Reisinger KS, Wiedmann RT, Sheaffer CI, Malacaman EA, Senders SD, Marchant CD, Protocol 009 Study Group for M-M-RII, Giacoletti KED, Shaw EE, Schodel FP, Musey LK, 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 1/1/2004
• Administration of a combination measles, mumps, rubella and varicella vaccine (ProQuad™) to 4- to 6-year-old children previously vaccinated with M-M-R™II and VARIVAX.
  Reisinger KS, Hoffman ML, Xu J, Sullivan BJ, Marshall GS, Nauert BW, Matson DO, Silas PE, Study Group for ProQuad, 38th Annual National Immunization Conference., Nashville, TN, 1/1/2004
• Join now to see all

Lectures

• Infectious and Noninfectious Causes of Recurrent and Periodic Fevers 
  National Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/25/2019
• Pediatrics for the Practitioner 
  Texas Health Science Center at San Antonio, San Antonio, TX - 1/7/2007
• Invited testimony on meningococcal disease (HB 342, requiring colleges to educate freshmen about the risks of meningitis and the benefits of immunization) before the H... 
  Frankfort, KY - 1/26/2004
• Pediatric Infectious Disease Update 
  University of South Carolina Beaufort, Hilton Head, SC - 1/14/2004
• A Review of Developmental/Behavioral Disorders and A Spectrum of Pediatric Challenges 
  Hackensack University Medical Center and the Joseph M. Sanzari Children's Hospital, Hilton Head, SC - 1/22/2003
• Invited testimony on vaccine safety before the Interim Joint Committee on Health and Welfare Families and Children Subcommittee 
  Frankfort, KY - 1/19/2003
• Tick-Borne Diseases in Children 
  Steamboat Springs, CO - 1/16/2003
• Immunizations: A Disease-Free Future for Families 
  Kansas City. MO - 1/13/2003
• Update on Issues and Challenges in Pediatric Immunization 
  Wayne State University School of Medicine and Children’s Hospital of Michigan, Detroit, MI - 1/29/2002
• Pediatric Infectious Disease: A Practical Approach to Current Issues 
  Indiana University School of Medicine, Indianapolis, IN - 1/13/2002
• PREP:ID, A Comprehensive Review and Update of Pediatric Infectious Diseases 
  Chicago, IL - 1/15/2001
• Chronic Fatigue Syndrome in Adolescents: State of the Art Workshop. 
  Washington, DC - 1/28/1998
• Focus on Pediatrics: Infectious Diseases 
  St. John’s Mercy Child Health Center, St. Louis, MO - 1/19/1995
• The Surgeon General's Workshop on Children with HIV Infection and Their Families. 
  Children's Hospital of Philadelphia, Philadelphia, PA - 1/6/1987
• Join now to see all

Other

• State has mandate to protect children from disease. 
  Marshall GS, Louisville Courier Journal
  1/5/2015
• Measles. (Radio Interview) 
  Marshall GS, WAVE-3 News
  Louisville, KY - 1/3/2015
• Immunization against rotavirus acute gastroenteritis: nearly 10 years after. Immunization Updates 2015;1:13-18 (continuing medical education monograph) 
  Marshall GS, Vindico Medical Education
  1/1/2015
• Vaccines: The strongest defense against many deadly diseases-Here's why they're safe and important. 
  Marshall GS, Vital Signs
  1/1/2012
• Investigational Hexavalent Combination Vaccine. (Radio Interview) 
  Marshall GS, WAVE-3 News
  Louisville, KY - 1/18/2011
• The Risk of Not Vaccinating Children. (Radio Interview) 
  Marshall GS, WUWM-89.7 FM
  Milwaukee, WI - 1/18/2011
• Importance of Vaccines. (Television Interview) 
  Marshall GS, WPGA (Mix in the Morning)
  Macon, GA - 1/15/2011
• Phase III Study of a New Pediatric Combination Vaccine. (Radio Interview) 
  Marshall GS, WKY Public Radio
  Louisville, KY - 1/12/2011
• Vaccines and autism. (Radio Interview) 
  Marshall GS, WAVE-3 News
  Louisville, KY - 1/6/2011
• Vaccines and autism. (Radio Interview) 
  Marshall GS, WHAS-11 News
  Louisville, KY - 1/6/2011
• Rotavirus prevention: Taking every opportunity to reduce the burden of disease. Continuing medical education monograph 
  Dennehy P, Marshall GS, Boston University School of Medicine and Haymarket Medical Education
  1/1/2011
• Three-part monograph on vaccine coverage: 1) Why Vaccination Timeliness Matters; 2) The Impact of Combination Vaccines on Improved Timeliness and Coverage; 3) Overcomi... 
  Pelton SI, Bernardi PG, Block SL, Marshall GS, Middleton DB, Stevenson AM, PRI Healthcare Solutions
  New York, NY - 1/1/2011
• Addressing Parents’ Concerns About Vaccines. Continuing nursing education DVD (NurseTIP—Immunization Training for Nurses) 
  Marshall GS, University at Albany School of Public Health, Center for Public Health
  1/1/2011
• Vaccinology 101. Continuing nursing education DVD (NurseTIP—Immunization Training for Nurses) 
  Marshall GS, University at Albany School of Public Health, Center for Public Health
  1/1/2011
• Vaccine safety. (Radio Interview) 
  Marshall GS, WKLY-32 News
  Louisville, KY - 1/31/2009
• The greatest risk is in not vaccinating kids. 
  Marshall GS, Milwaukee Wisconsin Journal Sentinel
  http://www.jsonline.com/news/opinion/64620527.html
  1/17/2009
• Pediatric Infectious Diseases in Children Aged 0-6 Years: Rationale for Early Immunization, Booster and Seroprotective Doses. Continuing medical education DVD 
  Marshall GS, Conway JH, Pelton S, Boston University School of Medicine and Med Learning Group
  1/1/2009
• Improving the quality of immunization care with combination vaccines. In: Pediatric Immunization: Meeting the Challenges of the 21st Century. Belshe RB, ed. Continuing... 
  Marshall GS, Vindico Medical Education
  http://www.pediatricsupersite.com/view.aspx?rid=43451
  1/1/2009
• Rotavirus: Providing optimal protection to overcome genetic diversity. Continuing medical education monograph 
  Marshall GS, Matson DO, Staat MA, Dennehy P, Vindico Medical Education
  1/1/2009
• Rotavirus Vaccine (Radio Interview) 
  Marshall GS, WAVE-3 News
  Louisville, KY - 1/5/2008
• A Comprehensive Overview of Rotavirus: Understanding Virology and Epidemiology to Effectively Manage and Prevent Disease. Continuing medical education DVD 
  Marshall GS, Dennehy PH, Staat MA, Postgraduate Institute for Medicine and Med Learning Group
  1/1/2008
• Rotavirus: Prevention and vaccination strategies to address burden of disease. Continuing medical education monograph 
  Marshall GS, Staat MA, Matson DO, Dennehy P, Vindico Medical Education
  1/1/2008
• Vaccines (Radio Interview) 
  Marshall GS, WDRB-Fox41 News
  Louisville, KY - 1/1/2007
• Rotavirus Gastroenteritis: Why Should We Care? Educational DVD and monograph 
  Marshall GS, Merck Vaccine Division
  1/1/2006
• Testing new rotavirus vaccines: Efficacy and safety. Continuing medical education monograph 
  Marshall GS, The Management and Prevention of Rotavirus
  1/1/2006
• Join now to see all